A Phase I, Multicentre, Open-Label, Two-Period, Randomized, Crossover Study Evaluating the Pharmacokinetics, Safety and Tolerability of Tecarfarin and Warfarin in Subjects with Severe Chronic Kidney Disease and Matched Healthy Volunteers

Trial Profile

A Phase I, Multicentre, Open-Label, Two-Period, Randomized, Crossover Study Evaluating the Pharmacokinetics, Safety and Tolerability of Tecarfarin and Warfarin in Subjects with Severe Chronic Kidney Disease and Matched Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Oct 2017

At a glance

  • Drugs Tecarfarin (Primary) ; Warfarin
  • Indications Thromboembolism; Thrombosis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 05 Oct 2017 New trial record
    • 12 Sep 2017 Results published in the Thrombosis and Haemostasis Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top